David J. Brenner

David J. Brenner

Auto-generated profile, based on publicly available information

David J. Brenner

Center for Radiological Research, Columbia University Irving Medical Center, New York, NY 10032, USA

Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 November 2007 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
DBDavid J. Brenner
David J. Brenner
EHEric J. Hall
Eric J. Hall
The advent of computed tomography (CT) has revolutionized diagnostic radiology. Since the inception of CT in the 1970s, its use has increased rapidly. It is estimated that more than 62 million CT scans per year are currently obtained in the United States, including at least 4 million for children.1

10 November 2003 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
DBDavid J. Brenner
David J. Brenner
RDRichard Doll
Richard Doll
DGDudley T. Goodhead
Dudley T. Goodhead
EHEric J. Hall
Eric J. Hall
CLCharles E. Land
Charles E. Land
MZMarco Zaider
Marco Zaider
High doses of ionizing radiation clearly produce deleterious consequences in humans, including, but not exclusively, cancer induction. At very low radiation doses the situation is much less clear, but the risks of low-dose radiation are of societal importance in relation to issues as varied as screening tests for cancer, the future of nuclear power, occupational radiation exposure, frequent-flyer risks, manned space exploration, and radiological terrorism. We review the difficulties involved in quantifying the risks of low-dose radiation and address two specific questions. First, what is the lowest dose of x- or γ-radiation for which good evidence exists of increased cancer risks in humans? The epidemiological data suggest that it is ≈10–50 mSv for an acute exposure and ≈50–100 mSv for a protracted exposure. Second, what is the most appropriate way to extrapolate such cancer risk estimates to still lower doses? Given that it is supported by experimentally grounded, quantifiable, biophysical arguments, a linear extrapolation of cancer risks from intermediate to very low doses currently appears to be the most appropriate methodology. This linearity assumption is not necessarily the most conservative approach, and it is likely that it will result in an underestimate of some radiation-induced cancer risks and an overestimate of others.

24 June 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MBManuela Buonanno
Manuela Buonanno
DWDavid Welch
David Welch
ISIgor Shuryak
Igor Shuryak
DBDavid J. Brenner
David J. Brenner
A direct approach to limit airborne viral transmissions is to inactivate them within a short time of their production. Germicidal ultraviolet light, typically at 254 nm, is effective in this context but, used directly, can be a health hazard to skin and eyes. By contrast, far-UVC light (207–222 nm) efficiently kills pathogens potentially without harm to exposed human tissues. We previously demonstrated that 222-nm far-UVC light efficiently kills airborne influenza virus and we extend those studies to explore far-UVC efficacy against airborne human coronaviruses alpha HCoV-229E and beta HCoV-OC43. Low doses of 1.7 and 1.2 mJ/cm2 inactivated 99.9% of aerosolized coronavirus 229E and OC43, respectively. As all human coronaviruses have similar genomic sizes, far-UVC light would be expected to show similar inactivation efficiency against other human coronaviruses including SARS-CoV-2. Based on the beta-HCoV-OC43 results, continuous far-UVC exposure in occupied public locations at the current regulatory exposure limit (~3 mJ/cm2/hour) would result in ~90% viral inactivation in ~8 minutes, 95% in ~11 minutes, 99% in ~16 minutes and 99.9% inactivation in ~25 minutes. Thus while staying within current regulatory dose limits, low-dose-rate far-UVC exposure can potentially safely provide a major reduction in the ambient level of airborne coronaviruses in occupied public locations.

1 September 2004 in Radiology
Verified
Journal Article
Closed access
DBDavid J. Brenner
David J. Brenner
CECarl D. Elliston
Carl D. Elliston
PURPOSE: To estimate the radiation-related cancer mortality risks associated with single or repeated full-body computed tomographic (CT) examinations by using standard radiation risk estimation methods. MATERIALS AND METHODS: The estimated dose to the lung or stomach from a single full-body CT examination is 14–21 mGy, which corresponds to a dose region for which there is direct evidence of increased cancer mortality in atomic bomb survivors. Total doses for repeated examinations are correspondingly higher. The authors used estimated cancer risks in a U.S. population derived from atomic bomb–associated cancer mortality data, together with calculated organ doses from a full-body CT examination, to estimate the radiation risks associated with single and multiple full-body CT examinations. RESULTS: A single full-body CT examination in a 45-year-old adult would result in an estimated lifetime attributable cancer mortality risk of around 0.08%, with the 95% credibility limits being a factor of 3.2 in either di...

1 January 2002 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
DBDavid J Brenner
David J Brenner
AMAlvaro A Martinez
Alvaro A Martinez
GEGregory K Edmundson
Gregory K Edmundson
CMChristina Mitchell
Christina Mitchell
HTHoward D Thames
Howard D Thames
EAElwood P Armour
Elwood P Armour